Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

5 Jan 2026 07:19

RNS Number : 6254N
Compagnie de Saint-Gobain
05 January 2026
 

Saint-Gobain strengthens its presencein construction chemicals in Indonesia

 

On December 30, 2025 Saint-Gobain formed a JV with a subsidiary of Indocement Tunggal Prakarsa (a publicly traded Indonesian cement company 53% owned by Heidelberg Materials) to acquire Indocement's mortars business in Indonesia. The JV will be 60% held by Saint-Gobain with the remaining 40% held by Indocement Tunggall Prakarsa.

 

Indocement's mortars business is well-established in Indonesia with three production lines under the Tiga Roda brand and estimated sales of close to €20 million in 2025. Tiga Roda is a leading brand in white skim coat for finishing and is very complementary to Saint-Gobain's existing mortars business, Cipta Mortar Utama (CMU), both in product categories and geographic reach, strengthening customer intimacy across Indonesia.

 

Saint-Gobain has been present in Indonesia since 1995 and currently operates 14 production lines and employs around 1,300 people in the country. CMU is the leading player on the Indonesian market, thanks to 8 mortars production lines across the country, a comprehensive product portfolio and a network of close to 30,000 points of sale. CMU also benefits from Saint-Gobain's large presence across construction chemicals in Indonesia, thanks to its GCP (concrete admixtures and cement additives) and FOSROC (cement additives, resin flooring and technical mortars) brands.

 

The newly formed JV will leverage the strengths of Saint-Gobain's CMU, as well as those of Indocement, a leading cement manufacturer in Indonesia, to accelerate growth on the promising mortars market.

 

This acquisition is part of Saint-Gobain's strategy to further strengthen its business profile, in line with its "Lead & Grow" plan. It enhances Saint-Gobain's presence in the high-growth Indonesian market and is fully aligned with the Group's strategy to strengthen its worldwide presence in construction chemicals.

 

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

 

 

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Karim Safsaf:

+33 1 88 54 00 60

Yanice Biyogo:

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBAMRTMTBMMIF
Date   Source Headline
6th Jan 20265:00 pmRNSIntention to delist from the London Stock Exchange
5th Jan 20267:19 amRNSAcquisition
8th Dec 20257:38 amRNSSaint-Gobain cancels 4.2 million shares
1st Dec 20254:58 pmRNSDisposal
30th Oct 20255:54 pmRNS3rd Quarter Results
6th Oct 20257:40 amRNSCapital Markets Day
2nd Oct 20255:10 pmRNSDisposal
1st Oct 20255:08 pmRNSDisposal
26th Sep 20255:14 pmRNSNew plant
8th Sep 20255:12 pmRNSNew construction chemicals organization in Germany
20th Aug 20257:15 amRNSDisposal
31st Jul 20255:51 pmRNSHalf-year Report
29th Jul 20255:10 pmRNSAcquisition
8th Jul 20255:10 pmRNSDisposal
18th Jun 20255:06 pmRNSAcquisition
5th Jun 20256:11 pmRNSNew organization
5th Jun 20255:53 pmRNSAGM Statement
4th Jun 20257:17 amRNSNew plant
20th May 20255:12 pmRNSNew plant
24th Apr 20255:31 pmRNS1st Quarter Results
22nd Apr 20257:00 amRNSSaint-Gobain featured on CDP’s “Climate A List”
26th Mar 20257:00 amRNSBond issue
27th Feb 20255:45 pmRNSAnnual Financial Report
21st Feb 20257:10 amRNSAppointment
10th Feb 20257:12 amRNSAcquisition
4th Feb 20254:54 pmRNSProduction line
16th Jan 20255:41 pmRNSFacility
15th Jan 20255:26 pmRNSAcquisition
3rd Dec 20245:26 pmRNSDecrease in capital
3rd Dec 20247:04 amRNSAcquisition
2nd Dec 20245:10 pmRNSAcquisition
2nd Dec 20247:06 amRNSDisposal
28th Nov 20245:15 pmRNSGovernance
7th Nov 20247:12 amRNSAgreement
29th Oct 20245:55 pmRNS3rd Quarter Results
14th Oct 20245:07 pmRNSAcquisition
8th Oct 20247:05 amRNSAgreement
10th Sep 20245:13 pmRNSDisposal
2nd Sep 20247:06 amRNSDisposal
15th Aug 20246:14 pmRNSAcquisition
31st Jul 20246:07 pmRNSIssue of Debt
26th Jul 20247:00 amRNSHalf-year Report
9th Jul 20247:08 amRNSAcquisition
27th Jun 20247:00 amRNSAcquisition
7th Jun 20247:00 amRNSAGM Statement
3rd Jun 20245:18 pmRNSAcquisition
2nd May 20245:34 pmRNSAgreement
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.